Ilika's broadening commercial pipeline supports broker's conviction in solid-state battery play

Ilika said its trading update was broadly in line with broker expectations, while making meaningful progress on commercialising both Stereax and Goliath battery platforms. The company now has evaluation agreements with 27 firms across automotive, defence and consumer sectors, indicating a widening commercialization pipeline. Cavendish reiterated a buy rating with a 130p target price versus 32.5p currently, implying 300% upside.

Analysis

The important read-through is not the headline progress itself, but the widening of Ilika’s option value across two very different end-markets. That matters because miniature industrial/defense applications can de-risk manufacturing know-how and customer qualification long before the larger EV-format platform proves itself, creating a staged monetization path that reduces binary dependence on any single program. In other words, the commercial pipeline is becoming more like a portfolio of low-probability, high-upside call options than a single product bet.

Second-order, the company’s growing evaluation base likely pressures adjacent suppliers and early-stage solid-state peers more than incumbents. If customer validation keeps broadening, the market may start to price Ilika less as an R&D story and more as a potential platform licensor/manufacturer, which can re-rate the equity sharply on each qualification milestone because today’s valuation likely embeds a very low probability of meaningful revenue inflection. The commercial signal is especially relevant in defense and industrial wearables, where reliability and footprint can outweigh cost—those segments can become the first “wedge” that funds the longer EV runway.

The main risk is timing slippage: these agreements can stay in evaluation for quarters, and solid-state history is full of pilots that never convert into volume. The catalyst path is therefore months, not days: conversion from evaluation to paid sampling, then to design wins, then to repeat orders. If conversion rates disappoint, the market can quickly re-assign the stock back to perpetual pre-revenue optionality; if one or two larger-format programs cross the line, the upside can be nonlinear.

Consensus appears to be underestimating how much a diversified pipeline reduces financing risk and improves negotiating leverage with strategic partners. The market often treats all pre-revenue battery developers as equivalent, but a company with multiple end-markets and a visible funnel has a materially better chance of surviving dilution cycles and extracting higher-value partnership terms. That makes this less about near-term earnings and more about the probability-weighted value of a future licensing/manufacturing platform.

Key Decisions for Investors

• Long Ilika on a 3-6 month horizon; size modestly because conversion risk is high, but the setup offers asymmetric upside if even one or two evaluation tracks convert into paid pilots. Use a tight risk limit: exit if no follow-through on customer conversion metrics within the next two updates.
• Buy call spreads rather than outright equity if liquid options are available; this caps downside while preserving upside into the next commercial milestone. Best suited for a 6-12 month window where re-rating can happen on design-win headlines.
• Pair trade: long Ilika versus short a basket of higher-valuation pre-revenue battery developers that lack multi-end-market validation. The thesis is relative de-risking; Ilika’s broader funnel should compress the probability gap if commercialization progress continues.
• Take profits into sharp spikes above obvious analyst targets or after partnership announcements; these names often overshoot on sentiment, then retrace until the next concrete milestone. Re-enter on post-event weakness if the pipeline remains intact.